2021

As the Chinese New Year approaches, the production of the COVID-19 vaccines is of great urgency, and its packaging needs to keep up with the pace in order to prevent the outbreak.On December 31th, 2020, the first COVID-19 vaccine was approved to be marketed in China with conditions. A number of other COVID-19 vaccine have also been carried out phase III clinical trials in overseas countries, and the research and development of the vaccine has entered the sprint phase and is ready for mass production. As a pharmaceutical packaging manufacturer, Sheng Zou Pharmaceutical Packaging & Device Technology (China) Co., Ltd. (hereinafter referred to as “ShengZou Group”) uses ExxPro ™ special elastomers to produce rubber products, which have already registered and applied to the packaging of the COVID-19 vaccines, and are widely used in sterile powder, freeze-dried, injection, pre-filled syringe and other pharmaceutical packaging materials. Shengzou Group has entered into a long-term contract with ExxonMobil Chemical, the supplier of ExxPro special elastomer raw materials, by cooperating with ExxonMobil Chemicals providing a steady supply of consistent quality raw materials, to assist the packaging production of the COVID-19 vaccines. Established in 1970, Shengzou Group has been engaged in pharmaceutical packaging materials for more than 51 years and has a number of subsidiaries